Mifamurtide sodium
Mifamurtide sodium is a therapeutic agent approved in Europe for treating osteosarcoma, a pediatric bone cancer. Its research applications include in vitro studies on macrophage activation and in vivo models investigating its immunomodulatory role in combination chemotherapy regimens.
Product Specifications
Field of Research
Immunology & Inflammation, Pharmacology & Drug Discovery
Molecular Weight
1259.48
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
EK346253 96 Well
Rabbit CYP1A2 (Cytochrome P450, family 1, subfamily A, polypeptide 2) ValidElisa Kit
Sign In for Pricing
View Details